Vaccine-associated non-scarring immune-mediated alopecia: insights from a pharmacovigilance analysis of the Vaccine Adverse Event Reporting System
Published: 5 December 2025| Version 1 | DOI: 10.17632/gn3whb89fg.1
Contributor:
Van Duc LeDescription
Supplemental Method
Files
Institutions
- Mayo Clinic Rochester
Categories
Methodology